High PTK2 expression was associated with lymph node metastasis stage, tumor stage, breast cancer type, age, TP53 mutation, and gender and significantly predicted a poor survival outcome in breast cancer patients. Here, TP53 is linked to metastatic malignant neoplasm in the lymph nodes.